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Purpose: To determine sequential intraocular pressure (IOP) changes after pars plana vitrectomy (PPV) with or 
without combined phacoemulsification and intraocular lens implantation (PE & IOL).
Methods: Consecutive patients who underwent PPV with PE & IOL (combined group) or without PE & IOL 
(vitrectomy group) were reviewed for postoperative sequential IOPs and the number of IOP lowering medications 
used. Of the 68 patients (68 eyes) who underwent simple PPV, 41 eyes were allocated to the vitrectomy group, 
and 27 eyes to the combined group.
Results: The mean IOPs were higher on postoperative days one and two, as compared to preoperative values, in 
both groups. The mean IOP changes on postoperative day one (10.0 mmHg vs. 5.3 mmHg, p= 0.02) and day two 
(3.7 mmHg vs. 1.3 mmHg, p= 0.02) were significantly higher in the combined group.
Conclusions: Phacovitrectomy is associated with a higher risk of IOP elevation during the early postoperative period 
than PPV alone. Caution should be exercised in patients who are vulnerable to IOP fluctuations when combined 
surgery is indicated.
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Cataract surgery combined with pars plana vitrectomy (PPV) 
has become more common since the development of the phaco-
vitrectomy technique. Significant lens opacities frequently de-
velop after PPV, especially in patients greater than 60 years of 
age, and some surgeons prefer phacovitrectomy to avoid the 
need for subsequent cataract surgery [1,2]. The surgeon usually 
has the option of choosing between phacovitrectomy and PPV 
alone in patients with vitreoretinal diseases, under the notion 
that the surgical outcomes are similar. Many reports have 
shown that combined cataract extraction and PPV is safe and 
effective, providing more rapid visual rehabilitation and having 
a similar complication rate to that observed in sequential sur-
gery [3,4].
Postoperative intraocular pressure (IOP) elevation is a fre-
quently encountered complication after PPV. Substantial IOP 
increase after PPV alone is found in up to 40% of patients within 
48 hours [5,6]. Around 15% to 56% of patients develop a tran-
sient IOP elevation within a few days after combined PPV and 
cataract extraction [3-11].
As in many other procedures combined with PPV, combined 
phacoemulsification and intraocular lens implantation (PE & 
IOL) may increase the risk for additional IOP elevation in the 
early postoperative period. Conversely, the long-term IOP low-
ering effect of cataract surgery may lead to decreased IOP in the 
late postoperative period [12]. We were unable to find any reports 
comparing postoperative IOP changes after PPV alone versus 
PPV with PE & IOL through a comprehensive Medline liter-
ature search. Therefore, we performed this study to evaluate se-
quential IOP changes after PPV with and without combined PE 
& IOL and to determine whether combined PE & IOL has any Korean J Ophthalmol Vol.24, No.6, 2010
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Table 1. Clinical characteristics of the patients who underwent vitrectomy with (combined group) or without cataract 
surgery (vitrectomy group)
Vitrectomy group
(n = 41)
Combined group
(n = 27) p-value
Age (yr)   63.3 ± 5.5 (55-72) 64.3 ± 3.0 (57-79) 0.06
*
Male  19 (46.3) 11 (40.7) 0.42
†
Preoperative IOP (mmHg) 14.3 ± 3.0 (9-20) 12.5 ± 2.1 (9-20) 0.01
*
Indications for vitrectomy
Proliferative diabetic retinopathy 19 (46.3) 16 (59.3) 0.12
†
Macular pucker    9 (22.0)   4 (14.8) 0.41
† 
Non-diabetic VH    5 (12.2)   6 (22.2) 0.15
†
Branched retinal vein occlusion without VH   4 (9.7)  0 (0.0) 0.12
†
Vitreomacular traction   0 (0.0)  1 (3.7) 0.40
†
Asteroid hyalosis   1 (2.4)  0 (0.0) 0.60
†
Central retinal vein occlusion   1 (2.4)  0 (0.0) 0.60
† 
Values are presented as mean ± SD (range) or number (%).
IOP = intraocular pressure; VH = vitreous hemorrhage.
*p-value by independent t-test; 
†p-value by Pearson’s chi-square test.
significant effect on early or late postoperative IOP changes af-
ter PPV.
Materials and Methods
The medical records of 68 patients who underwent PPV with 
and without cataract extraction were retrospectively reviewed. 
Forty-one eyes of 41 patients who underwent PPV alone were 
allocated to the vitrectomy group, and 27 eyes of 27 patients 
who underwent PPV with PE & IOL were allocated to the com-
bined group. All surgeries were performed by a single, experi-
enced vitreoretinal and cataract surgeon (KHP) between 
October 1, 2005 and October 30, 2006 at Seoul National 
University Bundang Hospital. Patients who underwent un-
complicated cataract surgery with PPV and who were followed 
for more than three months were enrolled in the study. Patients 
who underwent simple PPV were also enrolled. Patients with a 
history of any of the following conditions were excluded from 
the study: 1) underlying glaucoma, 2) high myopia, 3) prior in-
traocular surgery, 4) penetration injury of the eyeball, 5) severe 
proliferative vitreoretinopathy, 6) severe tractional retinal de-
tachment, 7) history of previous uveitis, 8) posterior capsule 
rupture during phacoemulsification, 9) intraoperative proce-
dure, such as silicone oil injection, cryotherapy, scleral buck-
ling, intravitreal gas injection, intravitreal triamcinolone in-
jection, or 10) endolaser photocoagulation of more than two 
quadrants of the retina [5,13].
 Preoperative data obtained from 
electronic medical charts included patient age, gender, oper-
ative eye, indication for surgery, history of previous ocular sur-
gery, IOP, anterior segment findings, and posterior segment 
findings. Thorough preoperative examinations were performed 
one to two days before surgery and included IOP measurement 
with a Goldmann applanation tonometer. 
In all cases, a traditional 20-gauge standard three-port PPV 
was performed. In the combined group, PE & IOL was per-
formed before PPV through a 2.75 mm superior clear corneal 
incision. A 10-0 nylon suture was applied to the corneal wound 
if there was any wound leakage. The same ocular viscoelastic 
device, Healon
 GV (sodium hyaluronate 1.4%), was used in all 
cases.
At each postoperative period, IOP, the number of glaucoma 
medications, complications, such as anterior chamber in-
flammation, angle closure, or synechiae, hyphema, vitreous 
hemorrhage, and secondary glaucoma status were recorded. 
Topical antibiotics and topical fluorometholone acetate (0.1%) 
were routinely used for one month. 
Statistical analyses were performed using SPSS ver. 15.0 
(SPSS Inc., Chicago, IL, USA). The paired t-test and Wilcoxon 
signed rank test were used to analyze postoperative IOP 
changes and the number of glaucoma medications, as com-
pared to preoperative data. The IOP ratio (postoperative 
IOP/preoperative IOP) was compared between the groups at 
each point using the independent t-test and Mann Whitney 
U-test. A p-value of < 0.05 was considered to be statistically 
significant.
Results
The patients’ preoperative data are shown in Table 1. 
Preoperative patient characteristics, including age, gender, and 
ratios of proliferative diabetic retinopathy were not sig-
nificantly different between the two groups, but the pre-
operative IOP was lower in the combined group (Table 1). The 
indications for PPV included complications from proliferative 
diabetic retinopathy (51.5%), such as vitreous hemorrhage and 
tractional retinal detachment, macular pucker (19.1%), and vit-
reous hemorrhage of non-diabetic etiology (16.2%), which 
were not significantly different between the two groups (Table 1). 
Indications for combined cataract surgery included a posterior 
subcapsular lens opacity score ≥ 3, nuclear opalescence/color
 
score ≥ 4, or cortical score ≥ 3, as measured by the Lens 
Opacity Classification System III [14]. The IOL was implanted HK Yang, et al. Intraocular Pressure after Vitrectomy
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Fig. 1. Sequential changes of postoperative intraocular pressure 
(IOP) after surgery in the vitrectomy group and combined group. 
Compared to the preoperative IOP values, postoperative IOP 
showed significant difference in early and late postoperative periods 
in the vitrectomy group and combined group. 
*p<0.05 by paired 
t-test in the vitrectomy group; 
†p<0.05 by paired t-test in the com-
bined group.
Fig. 2. Comparison of the sequential changes of intraocular 
pressure (IOP) ratio between the vitrectomy group and com-
bined group. The IOP ratios (postoperative IOP/preoperative 
IOP) were significantly higher in the combined group on post-
operative days one and two. 
*p<0.05 by independent t-test.
Table 2. The sequential changes of intraocular pressure (IOP) after surgery in the vitrectomy group and the combined 
group
Vitrectomy group
* Combined group
†
Mean IOP (mmHg) Range (mmHg) p-value
‡ Mean IOP (mmHg) Range (mmHg) p-value
‡
Preoperative 14.3 ± 3.0  9-20 - 12.5 ± 2.1 9-20 -
Postoperative
1 day 19.6 ± 7.2 10-38 < 0.01 22.4 ± 8.1 12-46 < 0.01
2 day 15.5 ± 3.5  9-22    0.03 16.2 ± 4.5  8-29 < 0.01
3 day 14.5 ± 3.1  8-20    0.37 14.4 ± 3.0  8-21     0.01
1 wk 13.2 ± 4.4  7-24    0.05 12.6 ± 3.4  7-19     0.46
3 wk 14.0 ± 5.3  5-31    0.35 11.8 ± 4.0  4-25     0.24
1 mon 11.9 ± 2.6  5-17 < 0.01 10.8 ± 2.3  5-17 < 0.01
2 mon 12.3 ± 3.1  7-22 < 0.01 10.7 ± 2.2  7-18 < 0.01
3 mon 12.9 ± 3.4  7-20 < 0.01 10.3 ± 2.2  6-15 < 0.01
*Patients who underwent only 20 gauge pars plana vitrectomy; 
†Patients who underwent 20 gauge pars plana vitrectomy combined with 
cataract extraction of phacoemulsification and intraocular lens implantation; 
‡p-value by paired t-test after comparison of preoperative and 
postoperative IOP.
in the bag in all cases.
Postoperative IOP change in the vitrectomy group, showed a 
significant IOP increase from 14.3 ± 3.0 mmHg (preoperative) 
to 19.6 ± 7.2 mmHg on postoperative day one (p < 0.01), and 
15.5 ± 3.5 mmHg on day two (p=0.03, paired t-test). The IOP 
was similar to the preoperative level at postoperative day three, 
week one, and week three. The IOP was actually lower than 
preoperative values at one, two, and three months postoper- 
atively. In the combined group, a significant IOP increase oc-
curred from 12.5 ± 2.1 mmHg (preoperative) to 22.4 ± 8.2 
mmHg on postoperative day one (p < 0.01), 16.2 ± 4.5 mmHg 
on day two (p < 0.01), and 14.4 ± 3.0 mmHg on day three (p <
0.01). The IOP returned to the preoperative level at post-
operative weeks one and three. The IOP was significantly low-
er than the preoperative values at months one, two, and three 
(Table 2 and Fig. 1).
IOP spikes ( ≥ 30 mmHg) occurred on postoperative day one Korean J Ophthalmol Vol.24, No.6, 2010
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Table 3. Comparison of mean intraocular pressure (IOP) ratio and IOP change (mmHg) between the vitrectomy group 
and the combined group after surgery
Postoperative
period
IOP ratio
* IOP change
† (mmHg)
Vitrectomy group Combined group p-value
‡ Vitrectomy group Combined group p-value
§
1 day 1.41 ± 0.56 1.83 ± 0.69 <0.01  5.3 ± 7.3 10.0 ± 8.2 0.02
2 day 1.12 ± 0.33 1.32 ± 0.37 0.02  1.3 ± 4.1   3.7 ± 4.6 0.02
3 day 1.04 ± 0.28 1.17 ± 0.27 0.97  0.2 ± 3.7  1.9 ± 3.3 0.05
1 wk 0.93 ± 0.30 1.02 ± 0.28 0.93 -1.1 ± 4.2   0.1 ± 3.6 0.23
3 wk 0.99 ± 0.34 0.98 ± 0.41 0.73 -0.3 ± 4.8 -0.7 ± 4.8 0.76
1 mon 0.86 ± 0.22 0.88 ± 0.23 0.67 -2.4 ± 3.2 -1.7 ± 3.2 0.41
2 mon 0.88 ± 0.22 0.88 ± 0.23 0.97 -2.0 ± 3.3 -1.7 ± 3.1 0.80
3 mon 0.92 ± 0.24 0.84 ± 0.21 0.17 -1.4 ± 3.4 -2.2 ± 3.0 0.33
*Postoperative IOP/preoperative IOP; 
†Postoperative IOP-preoperative IOP; 
‡p-value by independent t-test in comparison of the logarithmic 
value of IOP ratio at each postoperative time-point between the vitrectomy group and the combined group; 
§p-value by independent t-test in 
comparison of the mean IOP change at each postoperative time-point between the vitrectomy group and the combined group. 
Table 4. Univariate and multivariate analysis for risk factors of early intraocular pressure (IOP) elevation ≥10 mmHg 
on postoperative day one after vitrectomy
IOP increase 
≥10 mmHg 
on day 1
Odds ratio 95% confidence 
interval p-value
* Adjusted 
odds ratio
95% confidence 
interval p-value
†
Age at operation (yr)
<65 13/34 (38.2%) 2.012 0.703-5.790 0.19 2.473 0.740-8.263 0.14
≥65  8/34 (23.5%)
Gender
Male 11/30 (36.7%) 1.621 0.575-4.567 0.36 1.994 0.591-6.720 0.27
Female 10/38 (26.3%)
Preoperative IOP (mmHg)
≥13  9/38 (23.7%) 0.466 0.164-1.324 0.15 0.695 0.206-2.349 0.56
<13 12/30 (40.0%)
Diagnosis
PDR 15/35 (42.9%) 3.375 1.113-10.234 0.03 2.974 0.895-9.885 0.08
Non PDR
‡   6/33 (18.2%)
Combined cataract extraction
Yes 13/27 (48.1%) 3.830 1.301-11.280 0.01 3.591 1.047-12.319 0.04
No   8/41 (19.5%)
PDR = proliferative diabetic retinopathy. 
*p-value by Pearson’s chi square test; 
†p-value by linear logistic regression analysis; 
‡Branched retinal vein occlusion, central retinal vein 
occlusion, asteroid hyalosis, vitreomacular traction syndrome, macular pucker, vitreous hemorrhage with retinal tear or macroaneurysm.
in 9.8% (4/41) of patients in the vitrectomy group and in 14.8% 
(4/27) of patients in the combined group; there was no statisti-
cally significant difference between the two groups (p=0.70, 
Fisher’s exact test). The highest IOP recorded on postoperative 
day one was 36 mmHg in the vitrectomy group and 48 mmHg 
in the combined group. These patients showed severe in-
flammation in the anterior chamber, yet angles were widely 
open and were free of synechia. IOP lowering medications 
were prescribed for these patients, and none of the eyes showed 
IOP ≥ 30 mmHg after the second postoperative day.
The mean IOP change in the combined group was sig-
nificantly higher than that in the vitrectomy group on post-
operative days one (p=0.02) and two (p=0.02). The mean 
IOP changes were not significantly different between the two 
groups at any other timepoint (Table 3).
The IOP ratio was calculated at each postoperative time 
point, and the logarithmic value was compared between the two 
groups. The IOP ratios in the vitrectomy and combined groups 
were 1.41 ± 0.56 and 1.83 ± 0.69, respectively, on postoperative 
day one (p < 0.01); and 1.12 ± 0.33 and 1.32 ± 0.37, respectively, 
on postoperative day two (p=0.02, independent t-test). The IOP 
ratio was significantly higher in the combined group up to day 
two. The IOP ratios were not significantly different between 
the two groups at any other timepoint (Table 3 and Fig. 2).
There was no significant difference between the two groups 
with regard to the mean number of medications in use at any 
follow-up timepoint (p=0.12-0.96). Transient postoperative 
IOP elevation was well controlled with the use of glaucoma 
medications, and the mean number or glaucoma medications 
was less than 0.1 after the first postoperative week in both HK Yang, et al. Intraocular Pressure after Vitrectomy
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groups.
The risk factors associated with IOP increase ≥ 10 mmHg on 
day one after PPV were estimated using univariate and multi-
variate analyses (Table 4). Diabetic retinopathy (p=0.03) and 
combined cataract extraction (p=0.01) were significant risk 
factors by univariate analysis. However, multivariate analysis 
showed that combined cataract extraction was the only sig-
nificant risk factor (p=0.04, linear logistic regression analy-
sis). Stratified analysis controlling for diabetes also showed a 
significantly larger number of patients with IOP elevation on 
postoperative day one in the combined group (p=0.03, Mantel- 
Haenszel common odds ratio). 
Discussion
The major objectives of this study were to investigate the se-
quential IOP change after PPV and to determine the risk of 
combined PE & IOL on IOP elevation. In this study, an imme-
diate mean IOP rise was found up to two or three days after 
PPV. This transient IOP elevation following PPV, whether 
clinically significant or not, has been explained by open or 
closed angle mechanisms, including angiogenic, inflammatory, 
or blood-mediated factors [5,13]. A recent ultrasound bio-
microscopy (UBM) study by Lee et al. [15] reported a 42% in-
crease in ciliary body thickness and a decrease in anterior 
chamber depth after simple PPV, which persisted five days 
postoperatively.
 This time interval of ciliary body change was 
similar to the period of transient IOP elevation seen in our 
study.
According to our results, combined PE & IOL seems to exert 
an additive effect on transient IOP elevation after PPV, up to 
postoperative day two. It may be postulated that more in-
flammation of the trabecular meshwork was induced by cata-
ract surgery, leading to additional IOP elevation in the first few 
days after surgery. Combined cataract surgery may also cause 
anterior segment inflammation with disruption of the blood- 
aqueous barrier [16,17]. Unfortunately, we did not perform 
UBM of the ciliary body, and the precise mechanism of IOP 
change is unknown. Postoperative remnant materials in the an-
terior chamber are other potential causes of immediate IOP rise 
after cataract extraction.
 However, meticulous irrigation and 
aspiration were performed during cataract surgery to remove 
the viscoelastics and cortex; therefore, these factors are less 
likely to have contributed to postoperative IOP elevation.
Comparing with cataract surgery alone, previous studies 
agree that cataract surgery decreases IOP in the first few days 
after surgery in patients without underlying glaucoma [18-20]. 
Shingleton et al. [18] demonstrated an immediate IOP rise in 
the first few hours after cataract surgery, with 10% of patients 
showing an IOP spike of ≥ 35 mmHg IOP. However, a con-
tinuous decline of IOP was observed after this peak, and the 
mean IOP on postoperative day one decreased up to 5 mmHg 
[18-20]. In contrast, there are few studies concerning sequential 
IOP changes after PPV. Desai et al. [5] found that 40% of pa-
tients had IOP spikes requiring medications; however, IOP 
reached baseline within 24 hours. In our study, an IOP increase 
of 5 mmHg to 10 mmHg was observed on day one after PPV or 
phacovitrectomy. Although direct comparison is not possible 
due to different underlying conditions or surgical procedures, 
postoperative IOP seems to decline more rapidly after cataract 
surgery, while PPV or phacovitrectomy seems to increase IOP 
on the first couple of days before showing a decline [5,18-20]. 
With regard to IOP spikes ( ≥ 30 mmHg), 10% to 15% of pa-
tients in both groups showed an IOP spikes after PPV on post-
operative day one. These patients were associated with excessive 
inflammation and fibrin membranes in the anterior chamber 
greater than grade 3 and had an underlying retinal vascular dis-
ease of branched retinal vein occlusion or proliferative diabetic 
retinopathy. Fibrin membranes in the anterior chamber and pro-
liferative diabetic retinopathy are both identified to be risk fac-
tors of IOP elevation after intraocular surgery [4,5]. In our 
study, prompt initiation of IOP lowering medication restored 
the IOP levels to < 30 mmHg by the second postoperative day 
in all patients. Therefore, the clinical significance of transient 
postoperative inflammation and IOP spikes may be limited to 
those who are vulnerable to IOP fluctuation and who have low 
thresholds to optic nerve damage.
The late postoperative IOP lowering effect after PPV is an-
other interesting finding of this study. A significant decline of 
mean IOP after PPV was observed from the first postoperative 
month up to the end of follow-up in both groups.
 This late post-
operative IOP lowering effect has been described after simple 
cataract surgeries, but not after PPV or combined phacovi-
trectomy [12,18-22]. Instead, late postoperative glaucoma has 
been reported in up to 26% of patients after PPV [13,23].
 The 
difference between studies may be due to the presence of risk 
factors of IOP elevation in previous studies, e.g., a greater pro-
portion of severe diabetic retinopathy or complicated PPV, 
including combined procedures like scleral buckling and tam-
ponade with gas or silicone oil, etc. In the current study, only 
simple PPV cases were included, and we found no severe anterior 
chamber inflammation or late neovascular glaucoma in any of 
our patients, even in those with proliferative diabetic retinopathy.
The exact mechanism of long-term IOP reduction after PPV 
is unknown. Some reports have evaluated the ciliary body and 
angle opening with UBM after PPV, but there was no evident 
change after two months [15]. There is still the possibility of 
subtle structural change that might not have been detected with 
the UBM. Further investigations are required to reveal the 
long-term changes relating to increased outflow facility after 
PPV. On the other hand, the long-term IOP reduction after cata-
ract surgery has been explained by the improvement of outflow 
facility, deepening of the anterior chamber and posteriorization 
of the lens-iris diaphragm after cataract surgery [19,24,25].
 
These factors may also contribute after PPV, although the exact 
mechanism remains to be elucidated.
This study is limited by its retrospective nature and small 
number of cases. A relatively small number of patients were 
enrolled, because all possible confounding factors that might 
have influenced postoperative IOP changes were excluded. Korean J Ophthalmol Vol.24, No.6, 2010
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Secondly, the preoperative mean IOPs differed between the two 
groups. However, the mean baseline IOPs were both in the low 
teens (11-15 mmHg), and IOP ratios were compared to adjust 
for the preoperative difference. Finally, since the absolute 
values of IOP rise were relatively small, the clinical significance 
of such mild early postoperative IOP elevation may be argued. 
However, such rise may be critical to patients who are vulnerable 
to IOP fluctuations which must not be overlooked. Prophylactic 
glaucoma medications are known to be beneficial in preventing 
acute postoperative IOP spikes after cataract surgery in such 
patients [26,27].
In conclusion, combined PE & IOL and PPV are associated 
with a higher risk of IOP elevation than PPV alone during the 
early postoperative period. Fortunately, most of the pressure el-
evations are clinically insignificant or transient, which could be 
controlled medically. Nevertheless, caution should be exercised 
in patients whose optic nerves and retinal perfusion are vulner-
able to IOP fluctuations, especially when combined surgery is 
indicated.
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